EyePoint Pharmaceuticals is a leading biopharmaceutical company based in Watertown, MA, dedicated to developing innovative therapeutics for patients with serious retinal diseases. With a relentless commitment to science and technology, EyePoint aims to transform the treatment of wet AMD, NPDR, and DME, improving the lives of patients and delivering value to shareholders.
Utilizing cutting-edge science and innovation, EyePoint Pharmaceuticals strives to create a better future for patients by developing new solutions that can enhance vision and create a lifetime worth seeing. With a focus on scientific innovation and a strong pipeline of potential treatments, EyePoint is at the forefront of advancing retinal disease therapeutics.
Generated from the website